ethyl pyruvate has been researched along with Cognitive Dysfunction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Erdinc, M; Eriman, H; Kelle, I; Uyar, E | 1 |
Cho, E; Jeon, J; Jeon, SJ; Kim, DH; Kwon, H; Kwon, HJ; Kwon, KJ; Lee, YH; Moon, S; Park, AY; Shin, CY; Yi, JH | 1 |
Liang, F; Tang, Y; Tong, J; Xie, L; Yang, X; Yang, Y; Yuan, C; Zhao, K; Zhong, X; Zhong, Y | 1 |
3 other study(ies) available for ethyl pyruvate and Cognitive Dysfunction
Article | Year |
---|---|
Risperidone and ethyl pyruvate have protective effects against ketamine-induced cognitive impairments in mice.
Topics: Animals; Antipsychotic Agents; Cognitive Dysfunction; Ketamine; Mice; Pyruvates; Risperidone | 2022 |
Ethyl pyruvate prevents long-term stress-induced cognitive decline and modulates Akt/GSK-3β signaling.
Topics: Animals; Cognitive Dysfunction; Corticosterone; Glycogen Synthase Kinase 3 beta; Hippocampus; Long-Term Potentiation; Mice; Proto-Oncogene Proteins c-akt | 2023 |
Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Inflammasomes; Injections, Spinal; Male; Mice; Microglia; Neurons; NLR Family, Pyrin Domain-Containing 3 Protein; Protective Agents; Pyruvates; Sepsis-Associated Encephalopathy | 2020 |